Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT01280656
Eligibility Criteria:
Inclusion Criteria:
* Adult patients, \>/=18 years and \<70 years of age
* Diagnosis of hepatitis C
* Assessment of viral load prior to treatment (mandatory for genotype 1 only)
* Liver biopsy
* Co-morbidities data
* Use of interferon (pegylated or conventional) and ribavirin to treat hepatitis C infection genotype 2 and 3 and pegylated interferon plus ribavirin to treat hepatitis C infection genotype 1
* Above mentioned treatment started between 01-Sep-2007 and 31-Aug-2008
Exclusion Criteria:
* Co-infection with human immunodeficiency virus
* Co-infection with hepatitis B virus
* Presence of hepatocarcinoma
* Patients submitted to hemodialysis
* Organ transplant patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01280656
Study Brief:
Protocol Section:
NCT01280656